Simeprevir
RxNorm 1482790
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1482790 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: simeprevir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FN
Full form of descriptor (FN):
Product containing simeprevir (medicinal product)
(Atom ID: 10318887)
IN
Ingredient (IN):
Simeprevir
(Atom ID: 5911980)
PT
Designated preferred name (PT):
Simeprevir
(Atom ID: 7264120)
FN
Full form of descriptor (FN):
Simeprevir (substance)
(Atom ID: 7264121)
PT
Designated preferred name (PT):
Simeprevir-containing product
(Atom ID: 10820743)
Patient Education
Simeprevir
Simeprevir is used along with ribavirin (Copegus, Rebetol) and peginterferon alfa (Pegasys) to treat chronic hepatitis C (an ongoing viral infection that damages the liver). Simeprevir is in a class of medications called protease inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Simeprevir may not prevent the spread of hepatitis C to other people.
[Learn More]
* Please review the disclaimer below.